FDA to take action to address baby formula shortage by speeding review of imports

The White House said Monday that the Food and Drug Administration (FDA) will be working to expedite the importation of baby formula to address nationwide shortages caused in part by the shutdown of a major supplier in Michigan.

"FDA will prioritize review of applications that are most likely to be successful and will get the most formula to U.S. shelves as quickly as possible," White House press secretary Karine Jean-Pierre said at the White House briefing. "Companies will need to apply with the FDA, and FDA is prepared to review applications quickly and respond to them rapidly."

She promised, "All companies will meet the FDA's gold standard for quality control, and only safe products will come to America's shelves."